Literature DB >> 21952907

Predictors of survival among older adults with ependymoma.

E Susan Amirian1, Terri S Armstrong, Mark R Gilbert, Michael E Scheurer.   

Abstract

The biological process of aging encompasses a multitude of complex physiological and lifestyle changes that may alter the way typical prognostic factors affect survival among older ependymoma patients. Because very little is known about the clinical significance of traditional prognostic factors and the magnitude of their effects among older individuals, the purpose of this study was to evaluate the associations between survival and demographic and tumor characteristics among patients with ependymoma who were 60 years of age or older. Using the 1973-2007 dataset from the Surveillance, Epidemiology and End Results (SEER) program, we evaluated the impact of several factors on both overall and ependymoma-specific survival, utilizing multivariable Cox proportional hazards regression. We identified 367 ependymoma cases who were 60 years of age or older at diagnosis and had complete data from SEER. Of these, 19 (5.2%) had anaplastic tumors; all others were low-grade tumors. Age, tumor site, extent of surgery, and tumor histology were found to be significant predictors of ependymoma prognosis. The strongest predictor of poor outcome was supratentorial tumor location (adjusted HR: 6.94, 95% CI: 3.19-15.08, compared to spinal cord tumors). Our study suggests that tumor location, tumor histology, and surgical margin may be key predictors of survival among older ependymoma patients. We believe our study is one of the first to assess the prognostic value of these factors for ependymoma survival exclusively in an older patient population.

Entities:  

Mesh:

Year:  2011        PMID: 21952907      PMCID: PMC3863332          DOI: 10.1007/s11060-011-0730-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

Review 1.  Aging and immune function.

Authors:  R A Miller
Journal:  Int Rev Cytol       Date:  1991

2.  Intracranial ependymomas in children.

Authors:  J W Goldwein; J M Leahy; R J Packer; L N Sutton; W J Curran; L B Rorke; L Schut; P S Littman; G J D'Angio
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-12       Impact factor: 7.038

3.  Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients.

Authors:  Philippe Metellus; Jacques Guyotat; Olivier Chinot; Anne Durand; Marylin Barrie; Roch Giorgi; Anne Jouvet; Dominique Figarella-Branger
Journal:  Neuro Oncol       Date:  2010-05-19       Impact factor: 12.300

4.  Age-related physiological changes and their clinical significance.

Authors:  G R Boss; J E Seegmiller
Journal:  West J Med       Date:  1981-12

5.  Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

Authors:  Hyman B Muss; Susan Woolf; Donald Berry; Constance Cirrincione; Raymond B Weiss; Daniel Budman; William C Wood; I Craig Henderson; Clifford Hudis; Eric Winer; Harvey Cohen; Judith Wheeler; Larry Norton
Journal:  JAMA       Date:  2005-03-02       Impact factor: 56.272

6.  Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients.

Authors:  E G Shaw; R G Evans; B W Scheithauer; D M Ilstrup; J D Earle
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-10       Impact factor: 7.038

Review 7.  Gerontology as oncology. Research on aging as the key to the understanding of cancer.

Authors:  R A Miller
Journal:  Cancer       Date:  1991-12-01       Impact factor: 6.860

8.  Treatment of intracranial ependymomas of children: review of a 15-year experience.

Authors:  P Rousseau; J L Habrand; D Sarrazin; C Kalifa; M J Terrier-Lacombe; C Rekacewicz; A Rey
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-01-15       Impact factor: 7.038

9.  Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Authors:  Sandra M Swain; Fredrick S Whaley; Michael S Ewer
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

10.  Intracranial ependymoma long term outcome, patterns of failure.

Authors:  J J Kovalic; N Flaris; P W Grigsby; M Pirkowski; J R Simpson; K A Roth
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

View more
  14 in total

1.  Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Authors:  Elizabeth Vera-Bolanos; Kenneth Aldape; Ying Yuan; Jimin Wu; Khalida Wani; Mary Jo Necesito-Reyes; Howard Colman; Girish Dhall; Frank S Lieberman; Philippe Metellus; Tom Mikkelsen; Antonio Omuro; Sonia Partap; Michael Prados; H Ian Robins; Riccardo Soffietti; Jing Wu; Mark R Gilbert; Terri S Armstrong
Journal:  Neuro Oncol       Date:  2014-08-13       Impact factor: 12.300

2.  Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study.

Authors:  Ayal A Aizer; Marek Ancukiewicz; Paul L Nguyen; Shannon M Macdonald; Torunn I Yock; Nancy J Tarbell; Helen A Shih; Jay S Loeffler; Kevin S Oh
Journal:  J Neurooncol       Date:  2013-09-21       Impact factor: 4.130

3.  A multi-center retrospective analysis of treatment effects and quality of life in adult patients with cranial ependymomas.

Authors:  Stephan Dützmann; Bawarjan Schatlo; Alexander Lobrinus; Michael Murek; Maria Wostrack; Carolin Weiss; Karl Schaller; Andreas Raabe; Bernhard Meyer; Roland Goldbrunner; Kea Franz; Volker Seifert; Christian Senft
Journal:  J Neurooncol       Date:  2013-06-29       Impact factor: 4.130

Review 4.  Supratentorial extraventricular anaplastic ependymoma in an adult with repeated intratumoral hemorrhage.

Authors:  Naotaka Iwamoto; Yasuo Murai; Yoichiro Yamamoto; Koji Adachi; Akira Teramoto
Journal:  Brain Tumor Pathol       Date:  2013-04-02       Impact factor: 3.298

5.  Adult Supratentorial Extraventricular Anaplastic Ependymoma: Therapeutic Approach and Clinical Review.

Authors:  José Pedro Lavrador; Edson Oliveira; Joaquim Cruz Teixeira; José Pedro Lopes; José Pimentel; Manuel Herculano Carvalho
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar

6.  Comparison of epidemiology, treatments, and outcomes in pediatric versus adult ependymoma.

Authors:  Aladine A Elsamadicy; Andrew B Koo; Wyatt B David; Victor Lee; Cheryl K Zogg; Adam J Kundishora; Christopher S Hong; Tyrone DeSpenza; Benjamin C Reeves; Kristopher T Kahle; Michael DiLuna
Journal:  Neurooncol Adv       Date:  2020-02-21

7.  Ependymoma, NOS and anaplastic ependymoma incidence and survival in the United States varies widely by patient and clinical characteristics, 2000-2016.

Authors:  Rebecca L Achey; Sierra Vo; Gino Cioffi; Haley Gittleman; Julia Schroer; Vishesh Khanna; Robin Buerki; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neurooncol Pract       Date:  2020-05-09

8.  The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymoma.

Authors:  Roshan S Prabhu; Christopher D Corso; Matthew C Ward; John H Heinzerling; Reshika Dhakal; Zachary S Buchwald; Kirtesh R Patel; Anthony L Asher; Ashley L Sumrall; Stuart H Burri
Journal:  Neurooncol Pract       Date:  2019-12-19

9.  Anaplastic supratentorial cortical ependymoma presenting as a butterfly lesion.

Authors:  David W K Ng; Nicolas K K King; Aaron S C Foo; Yih-Yian Sitoh; Hwei Yee Lee; Wai Hoe Ng
Journal:  Surg Neurol Int       Date:  2012-09-13

10.  Descriptive epidemiology of ependymal tumours in the United States.

Authors:  J L Villano; C K Parker; T A Dolecek
Journal:  Br J Cancer       Date:  2013-05-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.